Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

445 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Keynote review: the adipocyte as a drug discovery target.
Nawrocki AR, Scherer PE. Nawrocki AR, et al. Among authors: scherer pe. Drug Discov Today. 2005 Sep 15;10(18):1219-30. doi: 10.1016/S1359-6446(05)03569-5. Drug Discov Today. 2005. PMID: 16213414 Review.
Adiponectin, an adipocyte-derived hepatic insulin sensitizer regulation during development.
Kim JY, Scherer PE. Kim JY, et al. Among authors: scherer pe. Pediatr Endocrinol Rev. 2004 Aug;1 Suppl 3:428-31. Pediatr Endocrinol Rev. 2004. PMID: 16444169 Review.
Role of resistin in diet-induced hepatic insulin resistance.
Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, Scherer PE, Rossetti L. Muse ED, et al. Among authors: scherer pe. J Clin Invest. 2004 Jul;114(2):232-9. doi: 10.1172/JCI21270. J Clin Invest. 2004. PMID: 15254590 Free PMC article.
Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes.
Tonelli J, Li W, Kishore P, Pajvani UB, Kwon E, Weaver C, Scherer PE, Hawkins M. Tonelli J, et al. Among authors: scherer pe. Diabetes. 2004 Jun;53(6):1621-9. doi: 10.2337/diabetes.53.6.1621. Diabetes. 2004. PMID: 15161771 Clinical Trial.
The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation.
Nawrocki AR, Scherer PE. Nawrocki AR, et al. Among authors: scherer pe. Curr Opin Pharmacol. 2004 Jun;4(3):281-9. doi: 10.1016/j.coph.2004.03.003. Curr Opin Pharmacol. 2004. PMID: 15140421 Review.
Hypothalamic resistin induces hepatic insulin resistance.
Muse ED, Lam TK, Scherer PE, Rossetti L. Muse ED, et al. Among authors: scherer pe. J Clin Invest. 2007 Jun;117(6):1670-8. doi: 10.1172/JCI30440. Epub 2007 May 24. J Clin Invest. 2007. PMID: 17525801 Free PMC article.
Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting.
Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS. Rajala MW, et al. Among authors: scherer pe. Diabetes. 2004 Jul;53(7):1671-9. doi: 10.2337/diabetes.53.7.1671. Diabetes. 2004. PMID: 15220189
Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the Women's Health Initiative.
Rajpathak SN, Kaplan RC, Wassertheil-Smoller S, Cushman M, Rohan TE, McGinn AP, Wang T, Strickler HD, Scherer PE, Mackey R, Curb D, Ho GY. Rajpathak SN, et al. Among authors: scherer pe. Stroke. 2011 Jul;42(7):1813-20. doi: 10.1161/STROKEAHA.110.607853. Epub 2011 May 5. Stroke. 2011. PMID: 21546486 Free PMC article.
Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages.
Kishore P, Li W, Tonelli J, Lee DE, Koppaka S, Zhang K, Lin Y, Kehlenbrink S, Scherer PE, Hawkins M. Kishore P, et al. Among authors: scherer pe. Sci Transl Med. 2010 Feb 24;2(20):20ra15. doi: 10.1126/scitranslmed.3000292. Sci Transl Med. 2010. PMID: 20371491
Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin.
Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, Patti ME, Klein SL, Weinstein RS, Scherer PE. Combs TP, et al. Among authors: scherer pe. Diabetes. 2003 Feb;52(2):268-76. doi: 10.2337/diabetes.52.2.268. Diabetes. 2003. PMID: 12540596
445 results
Jump to page
Feedback